Assessing the psychological and social effects of PCOS
The Psychological and Social Impact of PCOS
This study is trying to see how different factors like age and weight affect the quality of life for women with Polycystic Ovary Syndrome (PCOS).
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 1 site (Lille, Nord) |
| Trial ID | NCT05982236 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate how various factors such as age, BMI, and mental health history impact the quality of life in women diagnosed with Polycystic Ovary Syndrome (PCOS). Participants will complete an online questionnaire after their consultation in the Gynaecology or Reproductive Medicine Departments. The study will collect data progressively and securely store responses for analysis. The goal is to better understand the psychological and social implications of living with PCOS.
Who should consider this trial
Good fit: Ideal candidates are adult females aged 18 and over who have been diagnosed with PCOS according to the Rotterdam criteria.
Not a fit: Patients who do not speak or understand French or lack internet access may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved support and treatment strategies for women with PCOS, enhancing their quality of life.
How similar studies have performed: While there have been studies on PCOS, this specific focus on the psychological and social impacts is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female sex * Adult patient (aged 18 or over) * Able to read and write in French * diagnosed at a previous consultation as having PCOS according to the Rotterdam criteria (at least 2 out of 3 criteria from: * Clinical signs of hyperandrogenism (hirsutism, acne, androgenic alopecia) and/or biochemical signs of hyperandrogenism (total testosterone \> 0.39 ng/mL and/or androstenedione \> 1.75 ng/mL) * Ovulation disorders (infertility, oligomenorrhoea or amenorrhoea or cycle length either \<21 days or \>35 days), * Polymicrocystic ovaries on ultrasound (either 19 or more follicles measuring 2-9 mm in diameter and/or increased ovarian volume (\>10 cm3) and/or increased ovarian area (\> 5.5 cm²) without presence of cyst or dominant follicle.) * Informed consent Exclusion Criteria: * Patient with no health insurance cover * Difficulties understanding or speaking French * Computer (tablet/smartphone) and internet connection required. * Refusal to take part in research * Under court protection (guardianship/curatorship/privation of liberty)
Where this trial is running
Lille, Nord
- CHU de Lille Hôpital Jeanne de Flandre — Lille, Nord, France (Recruiting)
Study contacts
- Study coordinator: Aramatoulaye Sambou
- Email: drc@chru-lille.fr
- Phone: 0033 320444145
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.